DeutschNewstral
Article
pressherald.com on 2017-05-02 04:26
FDA OKs immune-boosting drug to treat advanced bladder cancer
Related news
FDA OKs drugs for bladder, blood cancersThe Salt Lake Tribune
FDA OKs new drug for bladder cancerabqjournal.com
FDA approves bladder cancer treatment by Culver City companyLA Times
Spectrum Pharma says U.S. FDA rejects its bladder cancer drugmetro.us
FDA grants approval for Astellas, Seattle Genetics' bladder cancer drugThe Jerusalem Post (JPost.com)
FDA lifts clinical hold; Heat's bladder cancer trial moves aheadbizjournals.com
ASU Alum Finding “Sweet” Success with Her Immune-Boosting Remedyhcpress.com
FDA Talks Regenerative Medicine Advanced Therapy Designationjdsupra.com
FDA OKs immunotherapy drugs for bladder, blood cancers - Wed, 18 May 2016 PSTThe Spokesman-Review
FDA considers implant to treat opiate addictionUSA today
Drug to treat alopecia approved by FDAFox News- TFDA panel rejects ecstasy to treat PTSDtheweek.com
FDA approves drug to treat depressionnwaonline.com- MFDA permits third dose for the immune-deficientmvtelegraph.com
FDA Approves Eisai’s Halaven to Treat Liposarcomawsj.com
FDA Approves New Drug to Treat MigrainesKTLA 5
FDA Approves Antibiotic to Treat Urinary InfectionsThe New York Times
FDA approves remdesivir to treat Covid-19CNN
FDA approves remdesivir to treat COVID-19reviewjournal.com
FDA approves drug to treat Alzheimer'sisraelnationalnews.com